Recent advancements in AI have led to the development of AlphaGeometry2 by Google DeepMind, which has surpassed human capabilities at the International Mathematical Olympiad by solving 84% of geometry problems in the last 25 years. This marks a significant improvement over its predecessor. Meanwhile, researchers are also working on developing new weight-loss drugs that promise to be more affordable and effective than existing options such as Ozempic, with candidates including Orforglipron and MariTide showing promise in clinical developments.
AlphaGeometry2, an AI from Google DeepMind, has outperformed human gold medalists in the International Mathematical Olympiad, solving 84% of geometry problems over the past 25 years.
Researchers are advancing weight-loss drug candidates that offer quick results and additional health benefits, marking a potential shift in obesity treatment.
Collection
[
|
...
]